Year |
Citation |
Score |
2023 |
Zhang C, Zaman LA, Poluektova LY, Gorantla S, Gendelman HE, Dash PK. Humanized Mice for Studies of HIV-1 Persistence and Elimination. Pathogens (Basel, Switzerland). 12. PMID 37513726 DOI: 10.3390/pathogens12070879 |
0.493 |
|
2023 |
Dash PK, Chen C, Kaminski R, Su H, Mancuso P, Sillman B, Zhang C, Liao S, Sravanam S, Liu H, Waight E, Guo L, Mathews S, Sariyer R, Mosley RL, et al. CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized mice. Proceedings of the National Academy of Sciences of the United States of America. 120: e2217887120. PMID 37126704 DOI: 10.1073/pnas.2217887120 |
0.513 |
|
2022 |
Waight E, Zhang C, Mathews S, Kevadiya BD, Lloyd KCK, Gendelman HE, Gorantla S, Poluektova LY, Dash PK. Animal models for studies of HIV-1 brain reservoirs. Journal of Leukocyte Biology. PMID 36044375 DOI: 10.1002/JLB.5VMR0322-161R |
0.443 |
|
2022 |
Kumari S, Dash PK, Kumari T, Guo ML, Ghosh JK, Buch SJ, Tripathi RK. HIV-1 Nef hijacks both exocytic and endocytic pathways of host intracellular trafficking through differential regulation of Rab GTPases. Biology of the Cell. PMID 35713972 DOI: 10.1111/boc.202100027 |
0.423 |
|
2021 |
Dash PK, Alomar FA, Cox JL, McMillan J, Hackfort BT, Makarov E, Morsey B, Fox HS, Gendelman HE, Gorantla S, Bidasee KR. A Link Between Methylglyoxal and Heart Failure During HIV-1 Infection. Frontiers in Cardiovascular Medicine. 8: 792180. PMID 34970611 DOI: 10.3389/fcvm.2021.792180 |
0.399 |
|
2021 |
Su H, Sravanam S, Sillman B, Waight E, Makarov E, Mathews S, Poluektova LY, Gorantla S, Gendelman HE, Dash PK. Recovery of Latent HIV-1 from Brain Tissue by Adoptive Cell Transfer in Virally Suppressed Humanized Mice. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 34528173 DOI: 10.1007/s11481-021-10011-w |
0.472 |
|
2021 |
Dash PK, Boix V. Fixed-dose darunavir/cobicistat in pregnancy of HIV-infected women, pharmacokinetic concerns. Aids (London, England). 35: 1301-1303. PMID 34076615 DOI: 10.1097/QAD.0000000000002886 |
0.313 |
|
2020 |
Dash PK, Alomar FA, Hackfort BT, Su H, Conaway A, Poluektova LY, Gendelman HE, Gorantla S, Bidasee KR. HIV-1-Associated Left Ventricular Cardiac Dysfunction in Humanized Mice. Scientific Reports. 10: 9746. PMID 32546795 DOI: 10.1038/S41598-020-65943-9 |
0.494 |
|
2020 |
Su H, Sravanam S, Gorantla S, Kaminski R, Khalili K, Poluektova L, Gendelman HE, Dash PK. Amplification of Replication Competent HIV-1 by Adoptive Transfer of Human Cells From Infected Humanized Mice. Frontiers in Cellular and Infection Microbiology. 10: 38. PMID 32117811 DOI: 10.3389/Fcimb.2020.00038 |
0.529 |
|
2020 |
Dash PK, Kevadiya BD, Su H, Banoub MG, Gendelman HE. Pathways towards human immunodeficiency virus elimination. Ebiomedicine. 53: 102667. PMID 32114397 DOI: 10.1016/J.Ebiom.2020.102667 |
0.547 |
|
2019 |
Mukadam IZ, Machhi J, Herskovitz J, Hasan M, Oleynikov MD, Blomberg WR, Svechkarev D, Mohs AM, Zhou Y, Dash P, McMillan J, Gorantla S, Garrison J, Gendelman HE, Kevadiya BD. Rilpivirine-associated aggregation-induced emission enables cell-based nanoparticle tracking. Biomaterials. 231: 119669. PMID 31865227 DOI: 10.1016/J.Biomaterials.2019.119669 |
0.481 |
|
2019 |
Hilaire JR, Bade AN, Sillman B, Gautam N, Herskovitz J, Shetty BLD, Wojtkiewicz MS, Szlachetka A, Lamberty B, Sravanam S, Fox H, Alnouti Y, Dash PK, McMillan JM, Edagwa BJ, et al. Creation of a long-acting rilpivirine prodrug nanoformulation. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 31491432 DOI: 10.1016/J.Jconrel.2019.09.001 |
0.337 |
|
2019 |
Dash PK, Kaminski R, Bella R, Su H, Mathews S, Ahooyi TM, Chen C, Mancuso P, Sariyer R, Ferrante P, Donadoni M, Robinson JA, Sillman B, Lin Z, Hilaire JR, et al. Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice. Nature Communications. 10: 2753. PMID 31266936 DOI: 10.1038/S41467-019-10366-Y |
0.561 |
|
2019 |
Su H, Cheng Y, Sravanam S, Mathews S, Gorantla S, Poluektova LY, Dash PK, Gendelman HE. Immune Activations and Viral Tissue Compartmentalization During Progressive HIV-1 Infection of Humanized Mice. Frontiers in Immunology. 10: 340. PMID 30873181 DOI: 10.3389/Fimmu.2019.00340 |
0.567 |
|
2018 |
Thomas MB, Gnanadhas DP, Dash PK, Machhi J, Lin Z, McMillan J, Edagwa B, Gelbard H, Gendelman HE, Gorantla S. Modulating cellular autophagy for controlled antiretroviral drug release. Nanomedicine (London, England). PMID 30129397 DOI: 10.2217/Nnm-2018-0224 |
0.327 |
|
2018 |
Sillman B, Bade AN, Dash PK, Bhargavan B, Kocher T, Mathews S, Su H, Kanmogne GD, Poluektova LY, Gorantla S, McMillan J, Gautam N, Alnouti Y, Edagwa B, Gendelman HE. Creation of a long-acting nanoformulated dolutegravir. Nature Communications. 9: 443. PMID 29402886 DOI: 10.1038/S41467-018-02885-X |
0.525 |
|
2018 |
Kevadiya BD, Woldstad C, Ottemann BM, Dash P, Sajja BR, Lamberty B, Morsey B, Kocher T, Dutta R, Bade AN, Liu Y, Callen SE, Fox HS, Byrareddy SN, McMillan JM, et al. Multimodal Theranostic Nanoformulations Permit Magnetic Resonance Bioimaging of Antiretroviral Drug Particle Tissue-Cell Biodistribution. Theranostics. 8: 256-276. PMID 29290806 DOI: 10.7150/Thno.22764 |
0.585 |
|
2018 |
Gendelman H, Dash P, Edagwa B, Gorantla S, Kaminski R, Bella R, Young W, Khalili K. D-110 Synergism between CRISPR/Cas9 and LASER ART leads to elimination of HIV-1 with no rebound in Humanized Mice Jaids Journal of Acquired Immune Deficiency Syndromes. 77: 42. DOI: 10.1097/01.Qai.0000532603.53717.02 |
0.456 |
|
2018 |
Su H, Dash P, Gorantla S, Poluektova L, Gendelman H. P-A8 Establishing tissue reservoirs for the human immunodeficiency virus in humanized mice Journal of Acquired Immune Deficiency Syndromes. 77: 55. DOI: 10.1097/01.Qai.0000532494.94287.Dd |
0.348 |
|
2017 |
Zhou T, Su H, Dash P, Lin Z, Dyavar Shetty BL, Kocher T, Szlachetka A, Lamberty B, Fox HS, Poluektova L, Gorantla S, McMillan J, Gautam N, Mosley RL, Alnouti Y, et al. Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles. Biomaterials. 151: 53-65. PMID 29059541 DOI: 10.1016/J.Biomaterials.2017.10.023 |
0.499 |
|
2017 |
Gnanadhas DP, Dash PK, Sillman B, Bade AN, Lin Z, Palandri DL, Gautam N, Alnouti Y, Gelbard HA, McMillan J, Mosley RL, Edagwa B, Gendelman HE, Gorantla S. Autophagy facilitates macrophage depots of sustained-release nanoformulated antiretroviral drugs. The Journal of Clinical Investigation. PMID 28134625 DOI: 10.1172/Jci90025 |
0.525 |
|
2017 |
Su H, Dash P, Arainga M, Edagwa B, Mcmillan J, Poluektova L, Gorantla S, Gendelman H. P-D4 Evaluation of Combination Long-Acting Nanoformulated Antiretroviral Therapy in HIV-1 Infected huPBL NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ MICE Journal of Acquired Immune Deficiency Syndromes. 74: 90. DOI: 10.1097/01.Qai.0000513994.51387.74 |
0.483 |
|
2017 |
Gnanadhas DP, Dash P, Silman B, Lin Z, Bade A, Gelbard H, Mcmillan J, Edagwa B, Gendelman H, Gorantla S. P-D2 Macrophage Autophagy Facilitates Sustained Release of Nanoformulated Antiretroviral Drugs From Autophagosomal Depots Enhances Anti-HIV-1 Activities Jaids Journal of Acquired Immune Deficiency Syndromes. 74: 89. DOI: 10.1097/01.Qai.0000513992.65741.3A |
0.454 |
|
2015 |
Zhang G, Guo D, Dash PK, Araínga M, Wiederin JL, Haverland NA, Knibbe-Hollinger J, Martinez-Skinner A, Ciborowski P, Goodfellow VS, Wysocki TA, Wysocki BJ, Poluektova LY, Liu XM, McMillan JM, et al. The Mixed Lineage Kinase-3 Inhibitor URMC-099 Improves Therapeutic Outcomes for Long-Acting Antiretroviral Therapy. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 26472049 DOI: 10.1016/J.Nano.2015.09.009 |
0.528 |
|
2015 |
Bade AN, Gorantla S, Dash PK, Makarov E, Sajja BR, Poluektova LY, Luo J, Gendelman HE, Boska MD, Liu Y. Manganese-Enhanced Magnetic Resonance Imaging Reflects Brain Pathology During Progressive HIV-1 Infection of Humanized Mice. Molecular Neurobiology. PMID 26063593 DOI: 10.1007/S12035-015-9258-3 |
0.538 |
|
2015 |
Puligujja P, Araínga M, Dash P, Palandri D, Mosley RL, Gorantla S, Poluektova L, McMillan J, Gendelman HE. Pharmacodynamics of folic acid receptor targeted antiretroviral nanotherapy in HIV-1-infected humanized mice. Antiviral Research. 120: 85-8. PMID 26026666 DOI: 10.1016/J.Antiviral.2015.05.009 |
0.539 |
|
2015 |
Puligujja P, Balkundi SS, Kendrick LM, Baldridge HM, Hilaire JR, Bade AN, Dash PK, Zhang G, Poluektova LY, Gorantla S, Liu XM, Ying T, Feng Y, Wang Y, Dimitrov DS, et al. Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations. Biomaterials. 41: 141-50. PMID 25522973 DOI: 10.1016/J.Biomaterials.2014.11.012 |
0.447 |
|
2014 |
Boska MD, Dash PK, Knibbe J, Epstein AA, Akhter SP, Fields N, High R, Makarov E, Bonasera S, Gelbard HA, Poluektova LY, Gendelman HE, Gorantla S. Associations between brain microstructures, metabolites, and cognitive deficits during chronic HIV-1 infection of humanized mice. Molecular Neurodegeneration. 9: 58. PMID 25523827 DOI: 10.1186/1750-1326-9-58 |
0.542 |
|
2013 |
Epstein AA, Narayanasamy P, Dash PK, High R, Bathena SP, Gorantla S, Poluektova LY, Alnouti Y, Gendelman HE, Boska MD. Combinatorial assessments of brain tissue metabolomics and histopathology in rodent models of human immunodeficiency virus infection. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 8: 1224-38. PMID 23702663 DOI: 10.1007/S11481-013-9461-9 |
0.492 |
|
2012 |
Dash PK, Gendelman HE, Roy U, Balkundi S, Alnouti Y, Mosley RL, Gelbard HA, McMillan J, Gorantla S, Poluektova LY. Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice. Aids (London, England). 26: 2135-44. PMID 22824628 DOI: 10.1097/Qad.0B013E328357F5Ad |
0.516 |
|
2012 |
Roy U, McMillan J, Alnouti Y, Gautum N, Smith N, Balkundi S, Dash P, Gorantla S, Martinez-Skinner A, Meza J, Kanmogne G, Swindells S, Cohen SM, Mosley RL, Poluektova L, et al. Pharmacodynamic and antiretroviral activities of combination nanoformulated antiretrovirals in HIV-1-infected human peripheral blood lymphocyte-reconstituted mice. The Journal of Infectious Diseases. 206: 1577-88. PMID 22811299 DOI: 10.1093/Infdis/Jis395 |
0.501 |
|
2012 |
Kadiu I, Narayanasamy P, Dash PK, Zhang W, Gendelman HE. Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages. Journal of Immunology (Baltimore, Md. : 1950). 189: 744-54. PMID 22711894 DOI: 10.4049/Jimmunol.1102244 |
0.531 |
|
2011 |
Gadad SS, Rajan RE, Senapati P, Chatterjee S, Shandilya J, Dash PK, Ranga U, Kundu TK. HIV-1 infection induces acetylation of NPM1 that facilitates Tat localization and enhances viral transactivation. Journal of Molecular Biology. 410: 997-1007. PMID 21763502 DOI: 10.1016/J.Jmb.2011.04.009 |
0.659 |
|
2011 |
Bethel-Brown C, Yao H, Callen S, Lee YH, Dash PK, Kumar A, Buch S. HIV-1 Tat-mediated induction of platelet-derived growth factor in astrocytes: role of early growth response gene 1. Journal of Immunology (Baltimore, Md. : 1950). 186: 4119-29. PMID 21368226 DOI: 10.4049/Jimmunol.1002235 |
0.49 |
|
2011 |
Dash PK, Gorantla S, Gendelman HE, Knibbe J, Casale GP, Makarov E, Epstein AA, Gelbard HA, Boska MD, Poluektova LY. Loss of neuronal integrity during progressive HIV-1 infection of humanized mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 3148-57. PMID 21368026 DOI: 10.1523/Jneurosci.5473-10.2011 |
0.484 |
|
2010 |
Sreenath K, Pavithra L, Singh S, Sinha S, Dash PK, Siddappa NB, Ranga U, Mitra D, Chattopadhyay S. Nuclear matrix protein SMAR1 represses HIV-1 LTR mediated transcription through chromatin remodeling. Virology. 400: 76-85. PMID 20153010 DOI: 10.1016/J.Virol.2010.01.017 |
0.628 |
|
2010 |
Eggert D, Dash PK, Gorantla S, Dou H, Schifitto G, Maggirwar SB, Dewhurst S, Poluektova L, Gelbard HA, Gendelman HE. Neuroprotective activities of CEP-1347 in models of neuroAIDS. Journal of Immunology (Baltimore, Md. : 1950). 184: 746-56. PMID 19966207 DOI: 10.4049/Jimmunol.0902962 |
0.502 |
|
2009 |
Eggert D, Dash PK, Serradji N, Dong CZ, Clayette P, Heymans F, Dou H, Gorantla S, Gelbard HA, Poluektova L, Gendelman HE. Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders. Journal of Neuroimmunology. 213: 47-59. PMID 19541372 DOI: 10.1016/J.Jneuroim.2009.06.002 |
0.454 |
|
2008 |
Dash PK, Siddappa NB, Mangaiarkarasi A, Mahendarkar AV, Roshan P, Anand KK, Mahadevan A, Satishchandra P, Shankar SK, Prasad VR, Ranga U. Exceptional molecular and coreceptor-requirement properties of molecular clones isolated from an Human Immunodeficiency Virus Type-1 subtype C infection. Retrovirology. 5: 25. PMID 18328091 DOI: 10.1186/1742-4690-5-25 |
0.653 |
|
Show low-probability matches. |